Please provide your email address to receive an email when new articles are posted on . Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular ...

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Abbott Laboratories (NYSE:ABT) announced Thursday that the U.S. Food and Drug Administration (FDA) cleared its Assert-IQ insertable cardiac monitor, a device to detect irregular heartbeats. Assert-IQ ...

Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long ...

Heart disease, particularly conditions like atrial fibrillation (AFib), is a leading cause of death worldwide, and traditional cardiac monitoring methods often present challenges in patient comfort ...

Gaston Emergency Medical Services is the first emergency services agency in North Carolina to receive a newly developed medical device that will help paramedics save the lives of cardiac patients. The ...

Wearlinq, maker of a wireless clinical-grade wearable 6-lead EKG, has secured a $14 million Series A investment and $5 million in venture debt funding. AIX Ventures led the Series A round, with ...

The wearable cardiac monitor maker VitalConnect has raised $100 million in new capital to aid in the development of its in-hospital wireless patient trackers while also expanding its commercial ...